Company: HURA
Filing Date: 2025-09-18
Form Type: S-1/A
Source: 0001193125-25-207395
Chunk: 300

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-09-18
Form: S-1/A
Chunk 300
---
. The fair value of the Series C Preferred Stock dividend paid on August 19, 2023, was determined by multiplying the dividends paid of 49 shares of common stock by the Company’s closing share price on August 18, 2023, of $ 3.53 per share for a total fair value of $ 173 . Any outstanding shares of Series C Preferred Stock will automatically convert to shares of common stock on August 19, 2024. In addition, as part of the Series C Preferred financing, the Company issued warrants to the placement agent (“Series C Agent Warrants”).

The Series C Preferred Stock shall with respect to distributions of assets and rights upon the occurrence of a liquidation, rank (i) senior to the Company’s common stock and (ii) senior to any other class or series of capital stock of the Company hereafter created which does not expressly rank pari passu with, or senior to, the Series C Preferred Stock. The Series C Preferred Stock is pari passu in liquidation to the Company’s Series A Preferred Stock. The liquidation value of the Series C Preferred Stock at December 31, 2023, is the stated value of $ 9,973 (June 30, 2023 - $ 10,366 ).

<div align='center'>F-5 8</div>

Table of Contents

Kintara Therapeutics, Inc. Notes to Condensed Consolidated Interim Financial Statements (Unaudited) December 31, 2023 (expressed in US dollars and in thousands, except par value and per share amounts, unless otherwise noted)

The Company’s Series C Preferred Stock outstanding, conversion shares, and aggregate dividends as of December 31, 2023, are as follows:

| Series   |     | Number |        |     | Conversionprice$ |       |     | Number ofconversionshares(in thousands) |     |     | Dividend Shares(in thousands) |     |
| Series 1 |     |        | 10,925 |     |                  | 58.00 |     |                                         | 188 |     |                               | 151 |
| Series 2 |     |        |    898 |     |                  | 60.70 |     |                                         |  15 |     |                               |  10 |
| Series 3 |     |        |  1,845 |     |                  | 57.50 |     |                                         |  32 |     |                               |